Microbot Medical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | +129.5% | – | |
| – | +75.0% | -20.0% | -50.0% | +64.3% | +13.0% | -42.3% | -20.0% | -16.7% | +0.0% | +930.0% | +758.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -32,250.0% | – | |
| – | -32.1% | +4.2% | +24.2% | +45.4% | -5.0% | -25.5% | +43.9% | -44.2% | +31.7% | -16.1% | +43.9% | – | |
| – | +0.6% | +29.5% | -10.0% | +13.3% | +16.6% | +8.0% | +3.2% | +66.9% | -11.4% | +27.1% | – | – | |
| – | -20.1% | +15.9% | +6.6% | +31.4% | +3.2% | -11.3% | +22.8% | +4.0% | +7.2% | +4.4% | +28.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.8% | -123.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.